Advanced RCC Can Still Respond to Nivolumab After Initial Progression

A subset of patients with advanced renal cell carcinoma experienced a reduction in tumor size after undergoing postprogression treatment with nivolumab.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news